Skip to main content
. 2022 Mar 4;2022(3):CD013739. doi: 10.1002/14651858.CD013739.pub2

Lins 2020.

Study name CoV‐Hep Study: randomized and paired clinical trial comparing regional anticoagulation modalities in continuous venous venous hemodialysis in patients with COVID‐19
Starting date 29 June 2020
Contact information Paulo Lins, MD
University of São Paulo General Hospital
São Paulo, SP, Brazil, 05403‐010
+55.11.98279‐2696 | paulo.lins@hc.fm.usp.br
Methods Open‐label, 2‐armed, parallel RCT
Participants 90 participants, ≥ 18 years, female and male
Inclusion criteria:
  • Confirmed or probable SARS‐CoV‐2 infection

  • Presence of acute kidney injury with indication and agreement between ICU and nephrology teams for the introduction of renal CVVHD


Exclusion criteria:
  • Hypersensitivity to any of the substances used in the study (citric acid dextrosol 2.2% and UFH)

  • Previous diagnosis of coagulopathy or thrombophilia

  • Contraindication to the use of UFH by the assistant team

  • Risk of citrate poisoning ‐ (lactate > 30 mg/dL, INR > 2.5, total bilirubin > 15mg/dL)

  • Pregnancy

Interventions Experimental:
  • Participants on continuous haemodialysis (blood flow 150 mL/min, dose of 30 mL/kg/h) receiving anticoagulation with sodium citrate at 4 mmol/L associated with UFH at 10 U/kg/h

  • Addition of UFH to CVVHD system already running under citrate regional anticoagulation


Comparator
  • Participants on continuous haemodialysis (blood flow 150 mL/min, dose of 30 mL/kg/h) receiving anticoagulation with sodium citrate at 4 mmol/L

Outcomes Primary
  • Clotted dialyzers (time frame: Day 3 of dialysis )

    • The percentage of clotted dialyzers within 72 h in each of the studied groups.


Secondary
  • Time‐free of clotting (time frame: day 3 of dialysis)

    • Number of h until a dialyser clots in the first 72 h of dialysis

  • Number of dialysers used (time frame: day 3 of dialysis)

    • The amount of dialysers used in the first 72 h of haemodialysis

  • Pressure variation (time frame: day 3 of dialysis)

    • Variation in dialysis system and vascular access pressures in the first 72 h of dialysis

  • Urea sieving (time frame: day 3 of dialysis)

    • Variation in urea sieving between the first, second and third days of dialysis

  • Downtime of dialysis (time frame: day 3 of dialysis)

    • Time of dialysis stop due to clotting in the first 72 h

Notes NCT04487990 | No data provided |